SCHEMBL6712571

SCHEMBL6712571

N[C@@H](CNC(=O)C=Cc1ccccc1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.59
MMP1 P03956 4/20 0.58
MMP2 P08253 4/20 0.58
MMP9 P14780 4/20 0.58
POLB P06746 1/20 0.55
RECQL P46063 1/20 0.55
HDAC3 O15379 2/20 0.54
HDAC4 P56524 2/20 0.54
HDAC1 Q13547 2/20 0.54
HDAC2 Q92769 2/20 0.54
HDAC8 Q9BY41 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
HTT P42858 1/20 0.54
GFPT1 Q06210 1/20 0.53
EGFR P00533 2/20 0.51
RAB9A P51151 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MEN1 O00255 2/20 0.50
ALDH1A1 P00352 2/20 0.50
MAOA P21397 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6712570 1.00 KMT2A (0.59) KMT2AMMP1MMP2MMP9POLB
SCHEMBL31560047 0.82 KMT2A (0.65) KMT2AMMP1MMP2MMP9POLB
SCHEMBL6713037 0.81 KMT2A (0.68) KMT2AMMP1MMP2MMP9POLB
SCHEMBL8230318 0.81 KMT2A (0.68) KMT2AMMP1MMP2MMP9POLB
N-Isobutylcinnamamide SCHEMBL11965211 0.81 KMT2A (0.63) KMT2AMMP1MMP2MMP9POLB
Hydrochloric Acid SCHEMBL333998 0.81 KMT2A (0.55) KMT2AMMP1MMP2MMP9POLB
Hydrochloric Acid SCHEMBL333997 0.81 KMT2A (0.55) KMT2AMMP1MMP2MMP9POLB
SCHEMBL8642620 0.79 KMT2A (0.61) KMT2AMMP1MMP2MMP9POLB
SCHEMBL8642621 0.79 KMT2A (0.61) KMT2AMMP1MMP2MMP9POLB
SCHEMBL15087822 0.79 KMT2A (0.61) KMT2AMMP1MMP2MMP9POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040048928-A1 Novel amino acid compounds and photoprotecting compositions comprised thereof L'OREAL (FR) 2004-03-11 US claimed
EP-1278718-B1 NOVEL AMINO ACID DERIVATIVES, PREPARATION METHOD, COMPOSITIONS CONTAINING SAME AND USES THEREOF AS SUNSCREENS OREAL (FR) 2003-12-17 EP claimed
US-20020150545-A1 Novel amino acid compounds and photoprotecting compositions comprised thereof L'OREAL (FR) 2002-10-17 US claimed
US-20040048928-A1 Novel amino acid compounds and photoprotecting compositions comprised thereof L'OREAL (FR) 2004-03-11 US disclosed
EP-1278718-B1 NOVEL AMINO ACID DERIVATIVES, PREPARATION METHOD, COMPOSITIONS CONTAINING SAME AND USES THEREOF AS SUNSCREENS OREAL (FR) 2003-12-17 EP disclosed
US-6641802-B2 Copper sulfat complexes to amino acid SOCIETE L'OREAL S.A. (FR) 2003-11-04 US disclosed
US-20020150545-A1 Novel amino acid compounds and photoprotecting compositions comprised thereof L'OREAL (FR) 2002-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020150545-A1 Novel amino acid compounds and photoprotecting compositions comprised thereof PELP1, ALAD, CRY1 KMT2A 3168/4885MMP1 1230/4885MMP2 1841/4885
US-20040048928-A1 Novel amino acid compounds and photoprotecting compositions comprised thereof PELP1, ALAD, CRY1 KMT2A 3168/4885MMP1 1230/4885MMP2 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.